ARTICLE
7 March 2023

Holland & Knight Health Dose: February 28, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
Holland & Knight are most popular:
  • within Strategy topic(s)

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • PAHPA Reauthorization RFI: Responses Due in Two Weeks
  • Capitol Hill's Push for PBM Reform
  • DEA Releases Proposed Rule to Scale Back COVID-Era Telehealth Policies
  • BPCI Advanced Model 2024 Application Portal Open
  • PHE Expiration

Read the full Health Dose

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More